Recombinant IL17A (Ixekizumab Biosimilar) antibody

Catalog No. ABIN7487783

This Mammalian Cells Monoclonal antibody specifically detects IL17A (Ixekizumab Biosimilar) in ELISA. It exhibits reactivity toward Human.

Quick Overview for Recombinant IL17A (Ixekizumab Biosimilar) antibody (ABIN7487783)

Target: IL17A (Ixekizumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Mammalian Cells

Clonality: Monoclonal

Conjugate: This IL17A (Ixekizumab Biosimilar) antibody is un-conjugated

Application: ELISA

Grade: Research Grade

Product Details anti-IL17A (Ixekizumab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Ixekizumab Biosimilar - Anti-IL17A mAb

Characteristics: Antibody Type: IgG4Kappa

Purification: Recombinant antibody expressed in mammalien cells and purified.

Isotype: IgG4 kappa

Application Details

Restrictions: For Research Use only

Handling

Buffer: PBS pH 7.5

Storage: 4 °C,-20 °C

Storage Comment: 4°C for short term, -20°C for long term

Target Details for IL17A (Ixekizumab Biosimilar)

Target: IL17A (Ixekizumab Biosimilar)

Target Type: Biosimilar

Background: Ixekizumab
Recombinant monoclonal antibody to IL17A. Ixekizumab is a humanized monoclonal antibody used in the treatment of autoimmune diseases.